Biotin interference can cause false-negative specific IgE results in patients with anaphylaxis

  • Nils Scheib
  • , Daniel Bauersachs
  • , Dimitrii Pogorelov
  • , Charlotte Mara Heinrich
  • , Feng Q. Hefeng
  • , Carsten Bindslev-Jensen
  • , Chrysanthi Skevaki
  • , Markus Ollert*
  • *Kontaktforfatter

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

122 Downloads (Pure)
OriginalsprogEngelsk
TidsskriftJournal of Allergy and Clinical Immunology: In Practice
Vol/bind10
Udgave nummer9
Sider (fra-til)2459-2462.e2
ISSN2213-2198
DOI
StatusUdgivet - sep. 2022

Bibliografisk note

Funding Information:
This work was partially supported by the Luxembourg National Research Fund (Fonds National de la Recherche/FNR) through the FNR-PRIDE program (PRIDE/11012546/NEXTIMMUNE) and the Ministry of Higher Education and Research of Luxembourg through Luxembourg Institute of Health (LIH) intramural funding. C. Skevaki is supported by the Universities Giessen and Marburg Lung Center, the German Center for Lung Research, University Hospital Giessen and Marburg research funding according to Article 2, Section 3 cooperation agreement, and Deutsche Forschungsgemeinschaft–funded SFB 1021 (C04), KFO 309 (P10), and SK 317/1-1 (Project 428518790) as well as by the Foundation for Pathobiochemistry and Molecular Diagnostics. Conflicts of interest: M. Ollert has been a consultant for HYCOR Biomedical, Siemens Healthineers, and Hitachi Chemical Diagnostics; and a speaker for Thermo Fisher Scientific, Siemens Healthineers, HYCOR Biomedical, and Allergy Therapeutics. C. Skevaki is a consultant and receives research funding from HYCOR Biomedical, Bencard Allergie, and Thermo Fisher Scientific; and receives research funding from Mead Johnson Nutrition. The rest of the authors declare that they have no relevant conflicts of interest.

Funding Information:
Conflicts of interest: M. Ollert has been a consultant for HYCOR Biomedical, Siemens Healthineers, and Hitachi Chemical Diagnostics; and a speaker for Thermo Fisher Scientific, Siemens Healthineers, HYCOR Biomedical, and Allergy Therapeutics. C. Skevaki is a consultant and receives research funding from HYCOR Biomedical, Bencard Allergie, and Thermo Fisher Scientific; and receives research funding from Mead Johnson Nutrition. The rest of the authors declare that they have no relevant conflicts of interest.

Funding Information:
This work was partially supported by the Luxembourg National Research Fund (Fonds National de la Recherche/FNR) through the FNR-PRIDE program (PRIDE/11012546/NEXTIMMUNE) and the Ministry of Higher Education and Research of Luxembourg through Luxembourg Institute of Health (LIH) intramural funding. C. Skevaki is supported by the Universities Giessen and Marburg Lung Center , the German Center for Lung Research , University Hospital Giessen and Marburg research funding according to Article 2, Section 3 cooperation agreement, and Deutsche Forschungsgemeinschaft–funded SFB 1021 (C04), KFO 309 (P10), and SK 317/1-1 (Project 428518790) as well as by the Foundation for Pathobiochemistry and Molecular Diagnostics.

Citationsformater